In particular, the therapeutic potential of phytochemical and synthetic compounds for NRF2 activation in attenuating oxidative damage associated in neurodegenerative diseases, cancer and cardiovascular diseases has been previously shown and discussed63–65. The gene discussed is NFE2L2; the disease is cancer.